 Nektar Therapeutics NASDAQ:NKTR Director Jeffrey Robert Ajer sold 2,250 shares of the stock in a transaction dated Monday, September 21st. The shares were sold at an average price of 19.74, for a total transaction of 44,415.00. Following the completion of the sale, the director now directly owns 20,125 shares in the company, valued at 397,267.50. ... 